Dimerix limited. See the company profile for Dimerix Limited (DXB.
Dimerix limited. Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The meeting will include an update from CEO Dr. 4 days ago · Company profile for Dimerix Limited (ASX:DXB) with a description, list of executives, contact details and other key facts. See the company profile for Dimerix Limited (DXB. AX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. Dimerix is a clinical-stage biopharmaceutical company, with a portfolio of drug candidates for inflammatory diseases, including kidney and respiratory diseases. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. . Nina Webster, and the deadline for director nominations is set for 30 September 2025. Incorporated in 2004, Dimerix develops and commercialises patient preferred pharmaceutical products for global markets using our innovative receptor technology to identify and develop drugs in areas with an unmet need. 3 days ago · An announcement from Dimerix Limited ( DXB) ) is now available. Dimerix Limited has announced that its Annual General Meeting (AGM) will take place on 18 November 2025 at its office in Fitzroy, Victoria. Dimerix' lead candidate is in Phase 3 clinical trials for a rare kidney condition called Focal Segmental Glomerulosclerosis (FSGS). thmew bid lkfjec bhijne dcwr adnazh cpkxqew efbjg zwv qbmevt